Please login to the form below

Not currently logged in
Email:
Password:
I have forgotten my password

cancer patients

This page shows the latest cancer patients news and features for those working in and with pharma, biotech and healthcare.

Sanofi patent case win holds off generic rivals for key cancer drug

Sanofi patent case win holds off generic rivals for key cancer drug

Lourie’s conclusion boosts Sanofi’s hopes of eking more money out of Jevtana, which came to market in 2010 as a treatment for prostate cancer patients. ... The performance made Jevtana Sanofi’s top selling cancer drug, accounting for almost 30% of

Latest news

More from news
Approximately 0 fully matching, plus 990 partially matching documents found.

Latest Intelligence

  • 25 Women Leaders in UK Healthcare 25 Women Leaders in UK Healthcare

    findings in up to half of cancer patients. ... Of equal importance is support for patients and families, especially in reaching a correct diagnosis as early as possible.

  • Genomics integration: can the NHS rise to the challenge? Genomics integration: can the NHS rise to the challenge?

    Last year, NHS England announced that it will focus on earlier diagnosis and more personalised medicines for cancer and rare disease patients, and it will further that goal by launching a ... The data has to be managed very carefully, with the benefits

  • Bringing life to precision medicine Bringing life to precision medicine

    Thus far, researchers have been unable to identify which cancer drug will work most effectively for specific patients, ie, precision medicine. ... A groundbreaking study in 2018 on patients with recurrent metastatic cancer showed that organoids are

  • Immuno-oncology in 2019: the rapid evolution continues Immuno-oncology in 2019: the rapid evolution continues

    lung cancer NSCLC patients with low PD-L1 expression (1%, also without EGFR or ALK mutations) – a group that was once thought unlikely to benefit from these drugs. ... April. Naturally Merck &Co isn’t confining itself to dominance in lung cancer.

  • Drug launches to watch in 2019 Drug launches to watch in 2019

    Around 10-20% of prostate cancer cases are castration-resistant, and up to 16% of these patients show no evidence that the cancer has spread at the time of the ... In patients with non-metastatic CRPC, there is a high unmet need to delay development of

More from intelligence
Approximately 0 fully matching, plus 52 partially matching documents found.

Latest appointments

  • F-star hires ex-BMS immuno-oncology leader

    pipeline. As we saw at the recent ASCO meeting, bispecific antibodies are leading a paradigm shift in cancer care and the potential to improve the outcome for cancer patients has never ... He is an active member of the American Society of Clinical

  • New hires at Ferring, Flexion and Immunocore New hires at Ferring, Flexion and Immunocore

    It’s the first major appointment for Ferring in 2019, and the company says Opdyke will lead the potential commercial launch of its investigational gene therapy for bladder cancer patients in ... He said: “At the heart of cancer immunity is a T cell

  • BMS appoints new commercial leader, Davies joins Eisai and more BMS appoints new commercial leader, Davies joins Eisai and more

    Apeiron expands board. Cancer Immunotherapy company Apeiron has expanded its board, appointing Anderson Gaweco as its chief medical and scientific officer. ... class new treatments for cancer patients and to help transform the company into a world-class

  • Sue Mahony to retire as president of Lilly Oncology Sue Mahony to retire as president of Lilly Oncology

    We make medicines that help patients with cancer live longer and what a privilege it’s been to wake up each morning with that as my life’s work.”.

  • José Baselga joins BMS’ board of directors José Baselga joins BMS’ board of directors

    Dr Baselga is currently the physician in chief at Memorial Sloan Kettering Cancer Center, where he is responsible for the management of patients care, enhancing and expanding programmes in clinical and ... targeted cancer therapies and treating patients.

More from appointments
Approximately 0 fully matching, plus 32 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 1 fully matching, plus 61 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
huumun formerly PharmiWeb Solutions

huumun, is a digital transformation business. For us, digital transformation means using digital technologies, not just to turn an existing...

Latest intelligence

The relevance of patient perspectives to value
Exploring the evolution of patient involvement in health technology assessment, and the role of the patient voice in market access....
How is the NHS Long-term Plan being put into action?
Steve How, Paul Midgley and Oli Hudson, of Wilmington Healthcare, explore some of the changes that have occurred since the plan was published...
real world studies
The evolution of real-world studies
How industry and regulators are using real-world data...

Quick links

Infographics

Multimedia